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Abstract Prokaryotic expression vector pMON3401 encoding
full size A(-1) ovine leptin was prepared by polymerase chain
reaction (PCR) of previously described cDNA. E. coli cells
transformed with this vector overexpressed large amounts of
ovine leptin upon induction with nalidixic acid. The expressed
protein found in the inclusion bodies was refolded and purified to
homogeneity on Q-Sepharose and SP-Sepharose columns,
yielding two electrophoretically pure fractions (leptin-Q and
leptin-SP), composed respectively of 90 and 95% of monomeric
protein of the expected molecular mass of 16 kDa. The purified
protein was capable of interacting with antibodies raised against
GST-ovine leptin and to bind specifically to ventromedial
hypothalamus of ewes. The biological activity of both fractions
resulting from proper renaturation was further evidenced by their
ability to stimulate DNA synthesis in leptin-sensitive BAF/3 cells
transfected with a long form of human leptin receptor construct.
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1. Introduction
Obese protein (OB), also known as leptin, serves as a pro-
tein signal secreted from adipose tissue and acts on a central
nervous system that regulates ingestive behavior and energy
balance [1]. Although the sequence of various leptins from 10
mammalian species was recently compiled and the three-di-
mensional structure of human leptin mutant W100E was re-
cently elucidated [2], so far only two recombinant mammalian
leptins (mouse and human) are available [3,4]. Recently a
more e⁄cient method for preparation of a renaturated re-
combinant human leptin overexpressed in E. coli was also
reported [5]. Although direct comparison of its biological po-
tency was not presented, the authors claim that the potency of
this refolded protein is similar to that of leptin secreted by E.
coli [3]. So far studies of leptin e¡ect were mainly limited to
rodents and the e¡ect of this protein on metabolism and nutri-
tional behavior of farm animals, which require large quanti-
ties of the recombinant leptin has not yet been investigated.
To answer this challenge we describe in the present paper a
highly e⁄cient method for preparation of biologically active
ovine leptin. Cloning of ovine leptin cDNA was recently de-
scribed [6] and its sequence deposited in GenBank (number
U84247). Ovine leptin has, respectively, 88% and 84% se-
quence identity to human and mouse leptins and di¡ers by
only two amino acids from bovine leptin [2,6].
2. Materials and methods
2.1. Materials
Carrier-free Na125I and [3H]thymidine were purchased from the
New England Nuclear Corp. (Boston, MA, USA). Molecular weight
(Mr) markers for gel electrophoresis, RPMI 1640 medium, nalidixic
acid, were obtained from Sigma Chemical Co. (St. Louis, MO, USA).
SDS-PAGE reagents were purchased from BioRad Laboratories
(Richmond, CA, USA). Superdex75 HR 10/30 column, SP-Sepharose
(fast £ow) and Q-Sepharose (fast £ow) were purchased from Pharma-
cia LKB Biotechnology AB (Uppsala, Sweden). All other chemicals
were of analytical grade.
2.2. Construction of ovine leptin expression vector
The synthetic gene for leptin was constructed using polymerase
chain reaction (PCR) technology, with a GeneAmpTM PCR Reagent
Kit (Perkin Elmer, Norwalk, CT, USA). Synthetic oligonucleotides
(primers) were used to generate a double-stranded DNA from a tem-
plate, of GST-leptin (Simmons and Keisler, unpublished results) in
addition to restriction enzyme sites for cloning. The forward primer
5P-GATATCGAATTCCCATGGCAGTGCCGATCCGCAAGGTC-
CAG encoded an NcoI restriction-enzyme site and an initiator me-
thionine codon immediately upstream to alanine codon and the ma-
ture leptin. The reverse primer 5P-GGATCCCTGCAGAAGCTTTC-
AGCAGCCGGGACTCAGGTC encoded the HindIII restriction site
and TAA termination codon immediately after the ¢nal codon (cys-
teine). PCR was performed using the Taq polymerase (20 cycles) and
the PCR product was cleaned, digested with NcoI and HindIII restric-
tion enzymes prior to ligation to parental vector pMON3401 using T4
DNA ligase. The ligation product was transfected to DHK5 E. coli
cells, prior to transformation of MON105 cells [7]. Automatic DNA
sequencing was performed to con¢rm the proper sequence.
2.3. Determination of the amino-terminal sequence
Automated Edman degradation technique was used to determine
the amino-terminal protein sequence. Degradations were performed
on an ABI Model 470A gas phase sequencer (Foster City, CA,
USA) using the standard sequencing cycle [8]. The respective PTH-
amino acid derivatives were identi¢ed by RP-HPLC analyses, using an
ABI Model 120A PTH analyzer ¢tted with a Brownlee 2.1 mm i.d.
PTH-C18 column.
2.4. Determination of purity and monomer content
SDS-PAGE was carried out according to Laemmli [9] using 15%
gel. Gels were stained with Coomassie Brilliant Blue R. HPLC gel-
¢ltration chromatography on a Superdex75 HR 10/30 column, using
25 mM Tris-HCl bu¡er, pH 8, containing 150 mM NaCl was per-
formed on 200-Wl aliquot of Q-Sepharose and SP-Sepharose columns-
eluted fractions and freeze-dried samples dissolved in H2O.
2.5. Binding experiments
Puri¢ed leptin-SP was iodinated by iodogen procedure according to
the protocol described previously for iodination of growth hormone
[10]. Slices of ovine hypothalamus were prepared as described previ-
ously [6] and the binding of iodinated leptin to the ventromedial
hypothalamus of food-restricted ewes was assayed using a protocol
described by Devos et al. [11].
2.6. Western analysis
The antiserum that we used to perform the Western was generated
in our laboratory. It was produced in a rabbit to GST-ovine leptin
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which we expressed (Simmons and Keisler, unpublished). One hun-
dred Wg of GST-ovine leptin in 0.5 ml saline was emulsi¢ed with 0.5
ml of Freund’s complete adjuvant. Three weeks later the rabbits were
retreated with 100 Wg of GST-ovine leptin in 0.5 ml of saline and 0.5
ml of Freund’s incomplete adjuvant and after an additional week the
antiserum was withdrawn. Standard SDS-PAGE and Western blot
techniques were used to determine whether antiserum produced in a
rabbit against GST-ovine leptin recognizes the two ovine leptin frac-
tions. Brie£y, samples were separated on 12.5% SDS-PAGE mini gels
and electrophoretically transferred to nitrocellulose membranes.
Membranes were incubated with polyclonal antisera to GST-ovine
leptin. Proteins were visualized after incubation with anti-rabbit IgG
alkaline phosphatase conjugated second antibody followed by nitro
blue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate (Prome-
ga, MD, WI, USA).
2.7. BAF/3 proliferation bioassay
The bioassay was based on incorporation of 3H-TdR into leptin-
sensitive BAF/3 1442-Cl 4 cells transfected with long form of human
leptin receptor according to a protocol described by Verploegen et al.
[12]. Human and mouse leptins that were used as positive controls
were prepared from the baculovirus infected cells [13].
3. Results and discussion
3.1. Expression, refolding and puri¢cation of ovine leptin
The sequence analysis of the cDNA revealed total identity
to the published sequence indicating that the PCR preparation
of the insert was correct. E. coli MON105 cells transformed
with the expression plasmids containing leptin cDNA were
incubated in 500 ml of Terri¢c Broth (TB) [14] medium by
shaking at 200 rpm at 37‡C in 3-l £asks to an A600 of 0.9, after
which nalidixic acid (50 mg/£ask) was added. The cells were
incubated an additional 4 h, harvested by 5-min centrifuga-
tion at 10 000Ug and frozen at 320‡C. In a preliminary ex-
periment performed with four clones the induced cells ex-
pressed leptin (V16 kDa) as a main cell protein (Fig. 1A)
and clone 011 was chosen for large-scale preparation. Over
95% of the leptin protein was found in the inclusion bodies
(Fig. 1B) which were according to the detailed procedure used
previously for preparation of bovine placental lactogen [15]
with two additional washings with 1% Triton X-100. The in-
clusion-body pellet obtained from 5 £asks was solubilized in
150 ml of 4.5 M urea bu¡ered with 10 mM Tris base. The pH
was increased to 11.3 with NaOH, cysteine was added to
1 mM, the clear solution was gently stirred at 4‡C for 6 h,
diluted with 3 vols of 0.67 M L-arginine and dialyzed for 48 h
against 5U10 l of 10 mM Tris-HCl, pH 8. The solution was
then loaded at 120 ml/h onto a Q-Sepharose column (20 ml
bead volume), pre-equilibrated with 10 mM Tris-HCl, pH 8.0
at 4‡C. Over 80% of the monomeric leptin was not absorbed
and was fully recovered in the breakthrough fraction (not
shown). The column was subsequently washed with 0.05 and
0.5 M NaCl (Fig. 2A). As evidenced by gel-¢ltration chroma-
tography on a Superdex75 column, the 0.05 M eluate con-
tained a fraction composed mainly of monomeric leptin
(over 90%) and dimers (V10%). A small quantity of dimeric
and oligomeric leptin was eluted with 0.5 M NaCl (Fig. 2A).
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Fig. 1. SDS-PAGE analysis of the expression of ovine leptin in ho-
mogenate of 4 clones of MON 105 E. coli bacteria transformed
with pMON3401 plasmid carrying leptin DNA (A) and in inclusion
bodies prepared from the same clones (B). Lane 1: molecular mass
markers (in kDa): 96, 66, 45, 35, 29, 24, 20 and 14.5; lanes 2, 4, 6,
and 8: homogenates or inclusion bodies from four clones without
induction; lanes 3, 5, 7 and 9: homogenates or inclusion bodies
from the respective clones 4 h after induction with nalidixic acid.
Lane 10: ovine placental lactogen (molecular mass 23 kDa). The
lane numbers in B correspond to the same numbers in A.
Fig. 2. Puri¢cation of inclusion bodies-extracted and refolded ovine
leptin on a Q-Sepharose (A) and SP-Sepharose (B) column. The
fraction containing inclusion body proteins solubilized in 4.5 M
urea in 40 mM Tris-HCl at pH 11.3 and dialyzed against 10 mM
Tris-HCl, pH 9, bu¡er (600 ml), was applied to the Q-Sepharose
column. Fractions eluted from the Q-Sepharose with 0.05 M NaCl
(see underlined peak) were pooled (leptin-Q). The non-absorbed elu-
ate (breatkthrough fraction) was collected, adjusted to pH 5 with
10% HAc and applied to an SP-Sepharose column. Fractions eluted
with 0.2 M NaCl (see underlined peak) were pooled (leptin-SP). For
other details see text.
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The breakthrough fraction from the Q-Sepharose column was
adjusted to pH 5 with 10% HAc and applied to a SP-Sephar-
ose column (1.2U8 cm) previously equilibrated with 25 mM
NaAc bu¡er, pH 5. Elution was carried out using a discon-
tinuous NaCl gradient in the same bu¡er at a rate of 90 ml/h,
and 10-ml fractions were collected (Fig. 2B). The pure mono-
meric leptin (as evidenced by gel ¢ltration on a Superdex
column) was eluted as a wide peak with 200 mM NaCl. Lep-
tin monomer-containing fractions from both columns (see
Fig. 2 underlined) were dialysed against 0.1% NaHCO3 and
lyophilized. Inclusion bodies prepared from 2.5 l fermentation
culture yielded V80 mg protein obtained from a Q-Sepharose
column (leptin-Q) and V250 mg protein obtained from a SP-
Sepharose column (Leptin-SP). As shown in Fig. 3, both frac-
tions contained almost pure monomeric protein with
RT = 12.38 and 12.41 min, respectively. Both fractions yielded
only one band ofV16 kDa on 15% SDS-PAGE performed in
the presence or absence of reducing agent (not shown). The
molar extinction coe⁄cient of ovine leptin at 280 nm was
calculated using the molar extinction coe⁄cients of tyrosine
(1197), yielding a value of 2394 M31 cm31. Amino-terminal
analysis of the ¢rst 6 amino acids yielded the expected se-
quence, namely AVPIRK in both fractions. Even though
there was a methionine codon prior to alanine, it was almost
completely cleaved by an amino peptidase [16]. Recent prep-
arations using bacterial cultures grown in 10-l fermentor en-
abled us to prepareV0.5 g of leptin-Q andV2 g of leptin-SP
from 10 l of bacterial culture (not shown).
3.2. Western analysis
Both Q- and SP-leptin fractions reacted with anti-GST-
ovine leptin antibody which also recognizes human and por-
cine leptin (Keisler and Simmons, unpublished data). Only
one band with a molecular mass of V16 kDa was observed
(not shown). This band did not react with preimmune control
sera.
3.3. Binding experiments
Incubation of ovine 125I-leptin (SP) with slices of ovine
hypothalamus (Fig. 4) clearly indicates speci¢c binding to
the ventromedial area (Fig. 4A). Total displacement of the
ovine 125I-leptin-SP was observed with addition of an excess
of unlabeled leptin (Fig. 4B).
3.4. Biological activity in vitro
The biological activity of both leptin fractions was com-
pared to that of human and mouse leptin (Fig. 5). The results
were analyzed by PRIZMA software [17] according to non-
linear regression sigmoidal dose-response curve. In all analy-
ses the goodness of ¢t for the non-linear correlation was very
high (R2s 0.97). Half of the maximal response (EC50) in
ovine-Q, ovine-SP, mouse and human leptins was achieved,
respectively, at a 2.28U10311, 3.47U10311, 4.72U10311 and
1.48U10310 M concentration. The di¡erences between the
EC50 values of two ovine fractions and the mouse leptin
were not statistically (Ps 0.05) signi¢cant. The maximal re-
sponse obtained with human leptin was slightly higher as
compared to ovine or mouse leptins.
3.5. Conclusion
Two electrophoretically pure recombinant ovine leptin frac-
tions (leptin-Q and leptin-SF) composed of over 90^95% of
monomer and a small quantity of dimers were obtained. Since
the N-terminal analysis of both fractions was identical we
assume that they di¡er by small charge change. The more
acidic fraction leptin-Q was likely created resulting by deam-
ination of one or more glutamine residues during the refolding
procedure at high pH. As shown above this di¡erence had no
e¡ect on the biological activity which was equal to that of
human and mouse leptins. The present method is su⁄cient
for preparation of large quantities of biologically active re-
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Fig. 4. Photomicrograph of a 12-Wm section of frozen ovine hypothalamus incubated with 125I-leptin indicating speci¢c binding to the ventro-
medial area (A). Displacement of 125I-leptin was observed with addition of an excess of unlabeled leptin (B).
Fig. 3. Gel ¢ltration of puri¢ed ovine leptin-Q and ovine leptin-SP
on a Superdex 75 HR 10/30 column. Aliquots (200 ml) of lyophi-
lized fractions (0.2 mg/ml) were applied to the column and the elu-
ate was monitored by absorbance at 280 nm. The column was de-
veloped with 25 mM Tris-HCl bu¡er, pH 8, containing 150 mM
NaCl at 1 ml/min and calibrated with bovine serum albumin (66
kDa, RT = 9.33 min), egg albumin (45 kDa, RT = 10.48 min), ex-
tracellular domain of hGH receptor (28 kDa, RT = 11.27 min) and
ovine placental lactogen (23 kDa, RT = 11.72 min).
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combinant ovine leptin which will allow future in vivo experi-
ments.
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Fig. 5. Biological activity of ovine leptin-Q (O), ovine leptin-SF
(P), human leptin-Sf9 (E) and mouse leptin-His6 (7) in BAF/3
cells transfected with the long form of human leptin receptor. DNA
synthesis was monitored by 3H-TdR incorporation. The results rep-
resent mean þ S.D. (n = 3). For other details see ref. [12].
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